Upcoming Live Events
There are currently no live events.
Past Live Events
Wed 11:00 AM PDT
HER2 IHC testing in the wake of the 2023 HER2 Breast Guideline Update¹ - Clinical Value, Classification & Scoring and the impact of the ASCO-CAP 2023 HER2 Breast Testing Guideline Update
This comprehensive session aims to support pathologists with clinical training to better understand the spectrum of HER2 IHC expression for identifying breast cancer...
Wed 12:00 PM CDT
HER2-low (IHC 1+ or IHC 2+/ISH-) Is a New Classification of HER2 Expression in Breast Cancer
HER2 has been, and continues to be, a practice-changing biomarker for guiding treatment decisions in breast cancer. Recently, a treatment option became available for...
Tue 3:30 PM PDT
HER2-low assessment: Challenges, Potential Solutions, and Clinical impact
The goal of this symposium is to educate about the advances in metastatic breast cancer diagnosis and treatment implications.
Tue 5:30 PM CDT
Optimizing Biomarker Testing in Resectable and Metastatic NSCLC: A Multidisciplinary Approach
This program will illustrate key best practices and new developments for biomarker testing in the care of patients with resectable and metastatic non-small cell lung...
Tue 12:00 PM CDT
Digital Pathology in Routine Practice: From AI to Z-Stacking
This presentation will highlight the progress in histopathology, image acquisition and image analysis in the field with a special emphasis on high throughput whole...
Mon 3:30 PM PDT
Breast Cancer Biomarkers: Current and Future Testing Strategies to Optimize Disease Management
This program provides an overview of the benefits and challenges of testing for various molecular biomarkers in breast cancer from the perspective of the pathologist.
Mon 12:00 PM CDT
Direct Diagnosis: How partnership and integration can improve the lives of patients
This session will follow a patient’s journey from initial biopsy to a clean bill of health, highlighting how digital pathology and AI products like Paige Breast and...
Mon 12:00 PM CDT
The Importance of Genomic Testing in Identifying Pathogenic Gene Fusions
Join us as we discuss the importance of the collaboration between pathology and medical oncology.
Wed 11:00 AM PST
VENTANA FOLR1 (FOLR1-2.1) RxDx Assay Overview
This comprehensive short course aims to support pathologists with clinical training to better understand FRα biology and scoring of this novel IHC marker for EOC samples.
Tue 11:00 AM PST
Discovering HER2-low: A subset of HER2 negative breast cancer
HER2-low (IHC 1+ or 2+/ISH-) is a newly defined subset of HER2 negative breast cancer, representing 60% of this patient population. With recent clinical advancements,...
Wed 11:00 AM PDT
Challenge accepted: Best practices for scoring HER2 IHC across the spectrum
In this concluding session, Shabnam Jaffer, MD, PhD, explores challenges and considerations when scoring HER2 by IHC, while Savitri Krishnamurthy, MD and Marilyn Bui,...
Wed 11:00 AM PDT
Consistency with practice: Standardizing the approach to HER2 IHC scoring
Throughout this comprehensive course, presenters will share their own best practice guidance for scoring HER2 – by interpretating and reporting discrete HER2 IHC...
Wed 11:00 AM PDT
From past to present: The significance of HER2 in Breast Cancer
Gain insight into how pathology practice will identify patients with all levels of HER2 expressing breast cancers, reinforcing current HER2 testing and interpretation...
Thu 11:00 AM PDT
What Have COVID-19 Autopsies Taught Us? - A Complimentary Update from USCAP and Cleveland Clinic
This session will give listeners an introduction to the pathology of COVID-19, with an emphasis on the lung, which is the main target of this disease. The relationship...
Thu 11:00 AM PDT
Gynecologic pathology: evolving concepts, classics, caveats
This session will discuss a selected but diverse group of gynecologic tract cases, highlighting some commonly encountered diagnostic problems and concepts. An emphasis...